The global medical protective clothing market size was valued at USD 373.7 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2020 to 2027. Rising demand for high-quality patient care in healthcare facilities is expected to have a positive impact on market growth. Medical protective clothing provides protection to doctors as well as patients from harmful pathogens. In addition, these clothing aids in preventing the spread of contagions, and hence are widely used during the COVID-19 pandemic to provide protection to the healthcare workers, including doctors, nursing professionals, and other hospital staff. According to the American Academy of Orthopedic Surgeons (AAOS), around 600,000 Total Knee Arthroplasty (TKA) surgeries were performed in 2010 in the U.S., which is estimated to reach over 3 million TKA procedures by 2030. Rising number of surgeries in the country is anticipated to boost the market growth in the U.S.
Ongoing innovations, coupled with advancements in the field of surgery, such as standardizing procedures, technical advancements, and high-reliability organizing (HRO), are anticipated to boost the growth of the hospital sector, thereby propelling the demand for medical protective clothing. Furthermore, rising prevalence of chronic diseases is likely to complement market growth.
Stringent government norms regarding the safety of patients, doctors, and other working employees in hospitals and premises, coupled with huge penalties for non-compliance with the standards, have prompted employers to use medical protective clothing in order to protect their employees against various infections and health hazards.
Adoption of appropriate protective clothing aids in protecting healthcare professionals (HCPs) and patients from high-consequence infectious diseases (HCIDs). The conformance of these medical protective clothing to the ASTM F1670 and ASTM F1671 standards for protection against blood, bodily fluids, and blood-borne pathogens is expected to have a positive impact on market growth.
Gowns held the largest market share of 41.9% in 2019 and are expected to witness the fastest growth from 2020 to 2027. Impermeable and fluid-resistant medical protective clothing such as surgical gowns and isolation gowns are used by healthcare professionals while treating patients infected with COVID-19. However, amidst the shortage, non-sterile disposable patient isolation gowns are being replaced by reusable gowns made from cotton-polyester or polyester fabrics as well as coveralls.
Coveralls are estimated to expand at a CAGR of 7.4% from 2020 to 2027 in terms of revenue on account of the ability of these medical protective clothing to provide 360° protection to the healthcare professionals. These medical protective clothing are designed to cover the entire body, including lower legs, back, head, and in some cases, feet.
In the U.S., the NFPA 1999 standard specifies the minimum performance, documentation, testing, certification, and design requirements for new multiple-use or single-use emergency medical protective clothing. Similarly, the gowns and coveralls used by the healthcare professionals during the COVID-19 pandemic are required to conform to the international standards, including EN14126 and EN13795, which provide protection against moderate to a high amount of body fluids.
In response to the medical protective clothing shortage during the COVID-19 pandemic, the HCPs are prioritizing the usage of coveralls during aerosol-generating procedures as well as while changing linens, providing hygiene, transferring, dressing, and assisting with toileting. In addition, adoption of surgical gowns is limited to surgical and other sterile procedures.
Hospitals dominated the market for medical protective clothing and held a share of 55.5% in 2019 and is anticipated to witness the fastest growth from 2020 to 2027. According to the U.S. Centers for Medicare & Medicaid Services (CMS), the healthcare spending in the U.S. witnessed growth by 4.6% in 2018, amounting to over USD 3.6 trillion, of which hospital care accounted for over USD 1.19 trillion. Rising prevalence of chronic diseases has resulted in increasing number of hospital visits and re-admissions, thereby having a positive impact on the demand for medical protective clothing in hospitals.
Rapidly growing geriatric population, coupled with increasing prevalence of hospital-acquired and other infections, such as hepatitis and AIDS, is anticipated to augment the demand for medical protective clothing in hospitals. In addition, introduction of reforms and initiatives in favor of medical protection in government hospitals is expected to drive the segment during the forecast period.
According to the American Academy of Family Physicians (AAFP), primary care services are the first point of contact in the healthcare system. It includes treatment and diagnosis of acute and chronic illness, patient education, counseling, health maintenance, and disease prevention. Increasing number of patients visiting primary care services for consultation is estimated to augment the segment growth.
Home healthcare facilities accounted for 21.9% share of the global revenue in 2019 on account of their ability to provide medical services to the patients, including skilled nursing, assisted living, and speech therapy, in the vicinity of their homes. Increasing elderly population is anticipated to have a positive impact on the demand for medical protective clothing in-home healthcare facilities.
Europe led the market for medical protective clothing with a revenue share of 34.3% in 2019. Germany is estimated to expand at a CAGR of 6.6% in terms of revenue from 2020 to 2027 on account of rising proportion of the elderly population in the country. Furthermore, increase in the number of same-day surgeries is anticipated to have a positive impact on the demand for medical protective clothing in the country.
Infectious diseases contributed to the health and economic problems in the U.K. and accounted for 7% of deaths in 2017. The national immunization program is considered to be an effective public health intervention in the U.K. Increasing number of infections creating health concerns in the U.K., coupled with policy related to antimicrobial resistance, has enhanced the healthcare sector in the country, thereby augmenting the market growth.
Asia Pacific is anticipated to expand at the fastest CAGR of 8.8% from 2020 to 2027. As per the International Society of Aesthetic Plastic Surgery, in 2016, 20% of women in Seoul had undergone plastic surgeries. South Korea had over 980,000 operations in 2014, the reason as explained by a plastic surgeon is, women in Eastern Asia have “monolid eyes,” so eyelid surgery is the most popular in the country, followed by body contouring, as it is cheaper in South Korea compared to other countries. Rising number of plastic surgeries is expected to augment the demand for medical protective clothing, such as surgical gowns, over the forecast period.
Japan is a disaster-prone country and has several hospitals, outpatient surgical/day centers, and emergency medical services (EMS). Furthermore, prevalence of chronic diseases in the country has prompted the government to take cost-saving initiatives, such as preventive care and chronic disease self-management. In Asia Pacific, Japan accounted for 11.4% share of the overall revenue in 2019 on account of rising medical innovation in the country.
Major market participants are focused on channelizing their efforts for new product and technology development by utilizing advanced methods for manufacturing cost-effective products. Furthermore, manufacturers of medical protective clothing are engaged in reducing the supply chain risks, while adhering to delivery requirements. Market players such as Honeywell, Lakeland Industries, DuPont, 3M, Alpha Pro Tech Limited, and Ansell have increased respective manufacturing capacities to supply PPE (Personal Protective Equipment), including medical protective clothing, to the HCPs during COVID-19 pandemic. Some of the prominent players in the global medical protective clothing market include:
Kimberly-Clark Worldwide, Inc.
Alpha Pro Tech
Derekduck Industries Corp.
Plasti Surge Industries Pvt.
Tronex International, Inc.
Market size value in 2020
USD 404.0 million
Revenue forecast in 2027
USD 661.0 million
CAGR of 7.4% from 2020 to 2027
Base year for estimation
2016 - 2018
2020 - 2027
Revenue in USD million and CAGR from 2020 to 2027
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, end use, region
North America; Europe; Asia Pacific; Central & South America; Middle East; Africa
U.S.; Canada; Mexico; U.K.; Germany; France; Russia; Spain; Italy; China; India; Japan; South Korea; Indonesia; Australia; Thailand; Malaysia; Brazil; Argentina; Saudi Arabia; United Arab Emirates; South Africa
Key companies profiled
3M; Ansell; Kimberly-Clark Worldwide, Inc.; Delta Plus; Alpha Pro Tech; Cardinal Health; Halyard Health; Lakeland, Inc.; Derekduck Industries Corp.; Plasti Surge Industries Pvt.; Tronex International, Inc.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at the global, regional, and country levels, and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global medical protective clothing market report on the basis of product, end use, and region:
Product Outlook (Revenue, USD Million, 2016 - 2027)
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Outpatient/Primary Care Facilities
Regional Outlook (Revenue, USD Million, 2016 - 2027)
Central & South America
United Arab Emirates
b. Some key players operating in the medical protective clothing market include 3M, Ansell, Kimberly-Clark Worldwide, Inc., Delta Plus, Alpha Pro Tech, Cardinal Health, and Halyard Health.
b. Key factors that are driving the market growth include increasing awareness for employee safety at healthcare facilities, the need for medical protective clothing for doctors, and sudden outbreak of pandemic across the globe.
b. The global medical protective clothing market size was estimated at USD 373.7 million in 2019 and is expected to reach USD 404.0 million in 2020.
b. The global medical protective clothing market is expected to grow at a compound annual growth rate of 7.4% from 2020 to 2027 to reach USD 661.0 million by 2027.
b. Europe dominated the medical protective clothing market with a share of 34.3% in 2019. This is attributable to the growing demand for medical clothing in hospitals owing to the sudden outbreak of the COVID-19 pandemic.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."